Impact of post-surgical freezing delay on brain tumor metabolomics.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
13 05 2019
Historique:
received: 22 01 2019
accepted: 04 05 2019
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 21 4 2020
Statut: epublish

Résumé

Translational cancer research has seen an increasing interest in metabolomic profiling to decipher tumor phenotypes. However, the impact of post-surgical freezing delays on mass spectrometric metabolomic measurements of the cancer tissue remains elusive. To evaluate the impact of post-surgical freezing delays on cancer tissue metabolomics and to investigate changes per metabolite and per metabolic pathway. We performed untargeted metabolomics on three cortically located and bulk-resected glioblastoma tissues that were sequentially frozen as duplicates at up to six different time delays (0-180 min, 34 samples). Statistical modelling revealed that 10% of the metabolome (59 of 597 metabolites) changed significantly after a 3 h delay. While carbohydrates and energy metabolites decreased, peptides and lipids increased. After a 2 h delay, these metabolites had changed by as much as 50-100%. We present the first list of metabolites in glioblastoma tissues that are sensitive to post-surgical freezing delays and offer the opportunity to define individualized fold change thresholds for future comparative metabolomic studies. More researchers should take these pre-analytical factors into consideration when analyzing metabolomic data. We present a strategy for how to work with metabolites that are sensitive to freezing delays.

Identifiants

pubmed: 31087206
doi: 10.1007/s11306-019-1541-2
pii: 10.1007/s11306-019-1541-2
doi:

Substances chimiques

Carbohydrates 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78

Références

Mol Oncol. 2018 Oct;12(10):1778-1796
pubmed: 30099851
Cancer Lett. 2018 Apr 10;419:103-115
pubmed: 29414301
Front Oncol. 2016 Jan 28;6:17
pubmed: 26858940
Cancer Cell. 2016 Jan 11;29(1):104-116
pubmed: 26766592
Bioinformatics. 2002;18 Suppl 1:S96-104
pubmed: 12169536
EBioMedicine. 2018 Feb;28:80-89
pubmed: 29396295
Cancer Lett. 2018 Aug 28;430:133-147
pubmed: 29777783
Nat Med. 2018 Feb;24(2):194-202
pubmed: 29334372
Nature. 2018 Jan 25;553(7689):511-514
pubmed: 29342136
Sci Signal. 2018 Jan 09;11(512):
pubmed: 29317520
Int J Cancer. 2019 Dec 15;145(12):3231-3243
pubmed: 30779128
J Natl Cancer Inst. 2018 Jun 1;110(6):588-597
pubmed: 29325144
Oncotarget. 2017 Dec 23;9(2):2678-2696
pubmed: 29416801
Electrophoresis. 2015 Dec;36(24):3050-60
pubmed: 26376450
Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-9
pubmed: 26979502
Sci Rep. 2017 Feb 22;7:43353
pubmed: 28225065
Gut. 2018 Jan;67(1):128-137
pubmed: 28108468
Anal Chem. 2009 Aug 15;81(16):6656-67
pubmed: 19624122
Cancer Cell. 2017 Jul 10;32(1):57-70.e3
pubmed: 28648284
Cancer Res. 2018 Jan 1;78(1):36-50
pubmed: 29097607
Cancer Res. 2017 Nov 1;77(21):e39-e42
pubmed: 29092936
Bioanalysis. 2015;7(8):927-30
pubmed: 25966004
Cancer Res. 2012 Nov 15;72(22):5878-88
pubmed: 23026133
Bioinformatics. 2018 Oct 1;34(19):3417-3418
pubmed: 29718102

Auteurs

Andreas Mock (A)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.
Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Carmen Rapp (C)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Rolf Warta (R)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Amir Abdollahi (A)

Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Dirk Jäger (D)

Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.

Oliver Sakowitz (O)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Benedikt Brors (B)

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Andreas von Deimling (A)

Department of Neuropathology & Clinical Cooperation Unit Neuropathology, University Hospital Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Christine Jungk (C)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Andreas Unterberg (A)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Christel Herold-Mende (C)

Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany. Christel.Herold-Mende@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH